|
End-of-day quote
Shenzhen S.E.
2026-09-24
|
5-day change | 1st Jan Change | ||
| 10.85 CNY | -1.90% |
|
-1.00% | -10.70% |
| Aug. 20 | Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| May. 22 | Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug | MT |
| Market Cap | 3.63B 541M 475M 449M 409M 765M 51.88B 771M 5.37B 2.08B 26.5B 2.03B 1.99B 85.18B | P/E 2024 |
79.5x | P/E 2025 | -63.9x |
|---|---|---|---|---|---|
| Enterprise Value | 3.91B 582M 511M 483M 440M 823M 55.82B 829M 5.78B 2.24B 28.52B 2.19B 2.14B 91.65B | EV / Sales 2024 |
2.95x | EV / Sales 2025 | 3.69x |
| Free-Float |
40.63% | Yield 2024 |
1.57% | Yield 2025 | - |
| 1 day | -1.90% | ||
| 1 week | -1.00% | ||
| Current month | -2.08% | ||
| 1 month | -0.28% | ||
| 3 months | +9.26% | ||
| 6 months | -26.89% | ||
| Current year | -10.70% |
| 1 week | 10.81 |  | 11.42 |
| 1 month | 10.53 | | 11.42 |
| Current year | 9.02 | | 18.96 |
| 1 year | 9.02 | | 18.96 |
| 3 years | 6.81 | | 19.56 |
| 5 years | 6.81 | | 22.25 |
| 10 years | 6.81 | | 22.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Liu
CEO | Chief Executive Officer | 50 | 2018-10-20 |
Shen Hua Shi
DFI | Director of Finance/CFO | 63 | 2011-04-15 |
Chun Yan You
PRN | Corporate Officer/Principal | 50 | 2018-01-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Xin Min Chen
CHM | Chairman | 60 | 2018-10-20 |
Zhi Jun Hua
CHM | Chairman | 57 | 2011-04-15 |
Jie Liu
BRD | Director/Board Member | 50 | 2020-03-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.90% | -1.00% | -16.15% | -16.41% | 541M | |
| +0.13% | +2.65% | +65.61% | +114.28% | 1,053B | |
| +0.20% | +0.46% | +52.60% | +69.24% | 652B | |
| -0.29% | +0.14% | +20.96% | +70.93% | 468B | |
| -0.85% | -0.25% | +38.63% | +44.47% | 351B | |
| +0.71% | +3.26% | +22.46% | +30.30% | 273B | |
| +1.23% | +1.00% | +11.97% | +13.63% | 254B | |
| +2.11% | +7.51% | +52.89% | +55.37% | 220B | |
| +0.83% | +0.55% | +35.99% | +101.70% | 186B | |
| 0.00% | -9.43% | -31.91% | -60.56% | 170B | |
| Average | +0.16% | +0.21% | +25.31% | +42.29% | 362.79B | |
| Weighted average by Cap. | +0.25% | +1.00% | +41.02% | +68.04% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.18B 176M 155M 146M 133M 249M 16.88B 251M 1.75B 677M 8.62B 661M 647M 27.72B | 1.18B 175M 154M 145M 132M 248M 16.8B 250M 1.74B 673M 8.58B 658M 644M 27.58B |
| Net income | 39.88M 5.94M 5.21M 4.92M 4.49M 8.4M 569M 8.46M 58.92M 22.82M 291M 22.31M 21.82M 935M | -63.47M -9.46M -8.3M -7.84M -7.14M -13.37M -906M -13.46M -93.77M -36.32M -463M -35.5M -34.73M -1.49B |
| Net Debt | 294M 43.79M 38.43M 36.29M 33.07M 61.91M 4.2B 62.35M 434M 168M 2.14B 164M 161M 6.89B | 276M 41.13M 36.09M 34.09M 31.06M 58.15M 3.94B 58.57M 408M 158M 2.01B 154M 151M 6.47B |
Employees
1,655
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | CN¥10.85 | -1.90% | 4,578,638 |
| 26-09-23 | CN¥11.06 | -1.60% | 4,881,500 |
| 26-09-22 | CN¥11.24 | -1.14% | 6,516,300 |
| 26-09-21 | CN¥11.37 | +4.12% | 8,368,740 |
| 26-09-18 | CN¥10.92 | -0.36% | 5,557,822 |
- Stock Market
- Stocks
- 002923 Stock
Select your edition
All financial news and data tailored to specific country editions
